News

Regeneron Continues To Regenerate Its Drug Pipeline, While Keeping Leverage Down
Regeneron earns a buy rating with strong profit margins, low debt, and growth potential. Discover why shares may see a 39% ...
Slator15h
US Bureau of Labor Statistics’ Job Outlook for Translators and Interpreters Worsens
The US BLS reports that the annual median salary for interpreters and translators jumped 5% in 2024, despite a slowdown in ...
MarketWatch17h
U.S. Dollar Index (DXY)
FTSE 100 Index 8,586.18 31.38 0.37% ...